BioCorRx Inc (BICX)
0.81
-0.09
(-10.00%)
USD |
OTCM |
May 17, 14:11
BioCorRx Enterprise Value: 8.646M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 8.646M |
| May 16, 2024 | 9.440M |
| May 15, 2024 | 8.646M |
| May 14, 2024 | 8.382M |
| May 13, 2024 | 8.382M |
| May 10, 2024 | 8.382M |
| May 09, 2024 | 8.382M |
| May 08, 2024 | 8.382M |
| May 07, 2024 | 8.382M |
| May 06, 2024 | 8.382M |
| May 03, 2024 | 8.118M |
| May 02, 2024 | 8.118M |
| May 01, 2024 | 8.118M |
| April 30, 2024 | 8.118M |
| April 29, 2024 | 8.118M |
| April 26, 2024 | 8.118M |
| April 25, 2024 | 8.735M |
| April 24, 2024 | 8.735M |
| April 23, 2024 | 8.118M |
| April 22, 2024 | 8.118M |
| April 19, 2024 | 14.46M |
| April 18, 2024 | 14.46M |
| April 17, 2024 | 14.46M |
| April 16, 2024 | 14.46M |
| April 15, 2024 | 14.73M |
| Date | Value |
|---|---|
| April 12, 2024 | 14.73M |
| April 11, 2024 | 11.47M |
| April 10, 2024 | 14.73M |
| April 09, 2024 | 14.73M |
| April 08, 2024 | 12.08M |
| April 05, 2024 | 11.47M |
| April 04, 2024 | 11.47M |
| April 03, 2024 | 11.64M |
| April 02, 2024 | 9.704M |
| April 01, 2024 | 9.396M |
| March 28, 2024 | 9.396M |
| March 27, 2024 | 9.440M |
| March 26, 2024 | 9.440M |
| March 25, 2024 | 9.352M |
| March 22, 2024 | 9.312M |
| March 21, 2024 | 9.312M |
| March 20, 2024 | 9.312M |
| March 19, 2024 | 9.312M |
| March 18, 2024 | 9.486M |
| March 15, 2024 | 9.486M |
| March 14, 2024 | 9.486M |
| March 13, 2024 | 9.486M |
| March 12, 2024 | 9.746M |
| March 11, 2024 | 9.746M |
| March 08, 2024 | 10.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.317M
Minimum
Jan 05 2021
38.07M
Maximum
May 13 2021
15.69M
Average
14.64M
Median
Mar 17 2021
Enterprise Value Benchmarks
| Encompass Health Corp | 11.84B |
| Pediatrix Medical Group Inc | 1.246B |
| US Physical Therapy Inc | 1.814B |
| The Oncology Institute Inc | 70.12M |
| American Oncology Network Inc | 236.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9685M |
| Revenue (Quarterly) | 0.0189M |
| Total Expenses (Quarterly) | 0.6988M |
| EPS Diluted (Quarterly) | -0.11 |
| Gross Profit Margin (Quarterly) | 31.08% |
| Profit Margin (Quarterly) | -5.11K% |
| Earnings Yield | -55.56% |
| Normalized Earnings Yield | -54.29 |